374 related articles for article (PubMed ID: 30006329)
1. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.
Masias C; Cataland SR
Blood; 2018 Aug; 132(9):903-910. PubMed ID: 30006329
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
Scully M
Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
[TBL] [Abstract][Full Text] [Related]
4. Rapid ADAMTS13 availability impacts treatment for microangiopathic hemolytic anemia and thrombocytopenia.
Martin IW; Katus MC; Martin CL; Szczepiorkowski ZM; Gorham JD; Dunbar NM
J Clin Apher; 2016 Oct; 31(5):419-22. PubMed ID: 26332753
[TBL] [Abstract][Full Text] [Related]
5. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
7. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
8. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
9. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
10. An Overview of Laboratory Testing for ADAMTS13.
Favaloro EJ; Pasalic L
Methods Mol Biol; 2023; 2663():481-486. PubMed ID: 37204731
[TBL] [Abstract][Full Text] [Related]
11. VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.
Schwameis M; Schörgenhofer C; Assinger A; Steiner MM; Jilma B
Thromb Haemost; 2015 Apr; 113(4):708-18. PubMed ID: 25503977
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
Chapman K; Seldon M; Richards R
Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
[TBL] [Abstract][Full Text] [Related]
13. A novel homozygous frameshift mutation in Exon 7 of the ADAMTS13 gene in a patient with congenital thrombotic thrombocytopenic purpura from India: a case report.
Yadav S; Shetty S; Kulkarni B
Transfusion; 2017 Nov; 57(11):2712-2714. PubMed ID: 28833243
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
15. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura.
Banno F; Kokame K; Okuda T; Honda S; Miyata S; Kato H; Tomiyama Y; Miyata T
Blood; 2006 Apr; 107(8):3161-6. PubMed ID: 16368888
[TBL] [Abstract][Full Text] [Related]
16. [Frontline clinical practice for thrombotic thrombocytopenic purpura].
Miyakawa Y
Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533
[TBL] [Abstract][Full Text] [Related]
17. Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura.
Roose E; Joly BS
Hamostaseologie; 2020 Aug; 40(3):322-336. PubMed ID: 32726827
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
Manea M; Karpman D
Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
Saha M; McDaniel JK; Zheng XL
J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
[TBL] [Abstract][Full Text] [Related]
20. Pediatric thrombotic thrombocytopenic purpura.
Joly BS; Coppo P; Veyradier A
Eur J Haematol; 2018 Oct; 101(4):425-434. PubMed ID: 29889319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
